PGF Pharma International d.o.o.
1 products tracked · names used in filings: PGF Pharma International d.o.o.
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Fri 21 Nov 2025🇪🇺 EU approval (EC decision)
Svariya (previously Rivaroxaban Koanaa) (rivaroxaban) approved in the EU
Marketing authorisation to PGF Pharma International d.o.o.; Generic · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Svariya (previously Rivaroxaban Koanaa) rivaroxaban | Authorised | 2025-11-21 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.